Collegium Pharmaceutical Inc (COLL)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 631,449 | 566,767 | 463,933 | 276,868 | 310,016 |
| Property, plant and equipment | US$ in thousands | — | — | 19,521 | 19,491 | 18,988 |
| Fixed asset turnover | — | — | 23.77 | 14.20 | 16.33 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $631,449K ÷ $—K
= —
The fixed asset turnover ratio for Collegium Pharmaceutical Inc has shown fluctuation over the years. In 2020, the company achieved a high fixed asset turnover of 16.33, indicating that its fixed assets were efficiently utilized to generate sales revenue. However, in 2021, this ratio decreased to 14.20, suggesting a potential decrease in the efficiency of the company's fixed asset utilization.
Subsequently, in 2022, Collegium Pharmaceutical Inc experienced a significant improvement in its fixed asset turnover, reaching a ratio of 23.77. This substantial increase indicates that the company was able to generate more sales relative to its investment in fixed assets during that period.
Unfortunately, the data for 2023 and 2024 are unavailable (denoted by "—"). It would be beneficial to have this missing information to assess the trend and performance of the company's fixed asset turnover consistently over time.
Overall, Collegium Pharmaceutical Inc's fixed asset turnover has displayed variability, showing both strengths and challenges in its ability to effectively leverage its fixed assets to drive sales.
Peer comparison
Dec 31, 2024